ArticleLangmuir : the ACS journal of surfaces and colloids2025
Selective Modulation of Lipid Langmuir Monolayers by Methyl Dehydrodieugenol: Insights into Its Interaction with Compressibility-Modulating Lipid Interfaces for Antiprotozoal Applications.
Article in Langmuir : the ACS journal of surfaces and colloids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the interaction of methyl dehydrodieugenol (MDHDE) with model lipid monolayers to elucidate its potential as a membrane-targeting therapeutic agent. Langmuir monolayer experiments were conducted using dioleoylphosphatidylcholine (DOPC), dioleoylphosphatidylethanolamine (DOPE), and cholesterol to mimic the compressible and condensed states of protozoal and mammalian membranes. Surface pressure-area isotherms revealed that MDHDE reduced the molecular packing density of the lipids at biologically relevant surface pressures, suggesting attractive interactions at the molecular level. While the surface compressional modulus decreased for all monolayers, the dilatational elasticity measurements indicated an increase in the elastic character of the DOPC monolayer upon MDHDE incorporation. Surface potential measurements indicated distinct effects on electrostatic properties, with MDHDE causing a sustained decrease in potential for DOPC and convergence of values at collapse for DOPE. Brewster angle microscopy showed increased domain density in DOPC and coalescence of domains in DOPE upon MDHDE incorporation, whereas cholesterol monolayers were unaffected. Polarization-modulation infrared reflection-absorption spectra confirmed MDHDE-induced changes in lipid surface arrangement and hydration in both hydrophobic and hydrophilic regions of the monolayers, demonstrating selective interactions based on lipid composition. These findings highlight the MDHDE's ability to modulate membrane properties in a lipid-dependent manner, underscore the importance of lipid selectivity in designing membrane-active compounds, and provide a foundation for the further development of MDHDE as an antiprotozoal agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.